Albert J G, Riemann J F
Department of Medicine, Klinikum Ludwigshafen, Academic Hospital of the University of Mainz, Ludwigshafen, Germany.
Best Pract Res Clin Gastroenterol. 2002 Jun;16(3):399-419. doi: 10.1053/bega.2002.0315.
Since the introduction of endoscopic retrograde cholangiopancreatography (ERCP) in the 1970s, gastroenterologists have a wide spectrum of diagnostic and therapeutic options in the biliopancreatic ductal system at their disposal. With its arrival in the 1990s, magnetic resonance cholangiopancreatography (MRCP) developed as a potent diagnostic tool in biliopancreatic pathology. Currently, MRCP is widely replacing diagnostic ERCP and thereby avoiding complications related to endoscopic technique.We summarize evidence-based data and demonstrate indications and differential indications for MRCP and ERCP in pancreatic disease. Complications related to the procedures and possible medical prevention are discussed. The feasibility of interventional endoscopy in pancreatic disease is reported in detail. The role of gastroenterologists in performing MRCP is outlined on the basis of practical examples.
自20世纪70年代引入内镜逆行胰胆管造影术（ERCP）以来，胃肠病学家在胆胰管系统中拥有广泛的诊断和治疗选择。随着20世纪90年代磁共振胰胆管造影（MRCP）的出现，它发展成为胆胰疾病的一种强大诊断工具。目前，MRCP正在广泛取代诊断性ERCP，从而避免与内镜技术相关的并发症。我们总结了基于证据的数据，并展示了MRCP和ERCP在胰腺疾病中的适应证和鉴别适应证。讨论了与这些操作相关的并发症及可能的医学预防措施。详细报道了介入性内镜检查在胰腺疾病中的可行性。基于实际案例概述了胃肠病学家在进行MRCP中的作用。
